Table 1.
Characteristics of individuals screened for SARS-CoV-2 and HCV antibodies by HCV findings.
| All screened for SARS-CoV-2-Ab, n = 5,152 |
Tested for HCV, n = 2,505 (48.6%) |
HCV-Ab positive, n = 72 (2.9%) |
HCV-Ab negative, n = 2,433 (97.1%) |
|
|---|---|---|---|---|
| n (%) or median (IQR) | n (%) or median (IQR) | n (%) or median (IQR) | n (%) or median (IQR) | |
| Town (residence, domicile, or workplace) | ||||
| Suisio | 1,126 (21.9) | 735 (29.3) | 20 (27.8) | 715 (29.4) |
| Sordio | 1,393 (27.0) | 585 (23.4) | 12 (16.7) | 573 (23.6) |
| San Pellegrino Terme | 2,633 (51.1) | 1,185 (47.3) | 40 (55.6) | 1,145 (47.1) |
| Age (years) | 50 (34-65) | 61 (53-71) | 63.5 (56-75) | 61 (52-71) |
| Males | 2,350 (45.6) | 1,118 (44.6) | 37 (51.4) | 1,081 (44.4) |
| Morbidities | ||||
| Smoking | 919 (17.8) | 428 (17.1) | 16 (22.2) | 412 (16.9) |
| Cardiovascular disease | 1,314 (25.5) | 957 (38.2) | 32 (44.4) | 925 (38.0) |
| Rheumatic diseases | 250 (4.9) | 165 (6.6) | 10 (13.9) | 155 (6.4) |
| Diabetes mellitus | 242 (4.7) | 183 (7.3) | 10 (13.9) | 173 (7.1) |
| Chronic lung diseases | 364 (7.1) | 177 (7.1) | 8 (11.1) | 169 (6.9) |
| Oncological diseases | 248 (4.8) | 173 (6.9) | 7 (9.7) | 166 (6.8) |
| Onco-hematological diseases | 38 (0.7) | 26 (1.0) | 1 (1.4) | 25 (1.0) |
| Solid neoplasms | 214 (4.2) | 150 (6.0) | 6 (8.3) | 144 (5.9) |
| Ever tested for HIV | 644 (25.7) | 23 (31.9) | 621 (25.5) | |
| HIV positive | 6 (0.2) | 2 (2.8) | 4 (0.2) | |
| HCV risk factors | ||||
| Piercings or tattoos | 115 (4.6) | 7 (9.7) | 108 (4.4) | |
| Ever received blood transfusions | 114 (4.6) | 11 (15.3) | 103 (4.2) | |
| Ever had sexual intercourse without a condom | 8 (0.3) | 2 (2.8) | 6 (0.2) | |
| Intravenous drug use | 0 (0.0) | 0 (0.0) | 0 (0.0) | |